ERWINAZE (Jazz Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the ERWINAZE drug offered from Jazz Pharmaceuticals, Inc.. This Asparaginase [Chemical/Ingredient],Asparagine-specific Enzyme [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Jazz Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | Asparaginase |
| SUBSTANCE NAME: | ASPARAGINASE ERWINIA CHRYSANTHEMI |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Asparaginase [Chemical/Ingredient],Asparagine-specific Enzyme [EPC] |
| ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2011-11-18 |
| END MARKETING DATE: | 0000-00-00 |
ERWINAZE HUMAN PRESCRIPTION DRUG Details:
| Item Description | ERWINAZE from Jazz Pharmaceuticals, Inc. |
| LABELER NAME: | Jazz Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10000([iU]/mL) |
| START MARKETING DATE: | 2011-11-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 57902-249_295824de-b262-411f-b934-e39deafb62a3 |
| PRODUCT NDC: | 57902-249 |
| APPLICATION NUMBER: | BLA125359 |
Other ASPARAGINASE ERWINIA CHRYSANTHEMI Pharmaceutical Manufacturers / Labelers:
